Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus. [electronic resource]
Producer: 20040430Description: 526-31 p. digitalISSN:- 0041-1337
- Adolescent
- Adult
- Antiviral Agents -- therapeutic use
- Child
- Child, Preschool
- Chronic Disease
- Cyclosporine -- therapeutic use
- Cytomegalovirus -- genetics
- Cytomegalovirus Infections -- prevention & control
- DNA, Viral -- analysis
- Female
- Graft vs Host Disease -- physiopathology
- Histocompatibility Testing
- Humans
- Immunosuppressive Agents -- therapeutic use
- Infant
- Living Donors
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Polymerase Chain Reaction
- Population Surveillance -- methods
- Postoperative Care
- Retrospective Studies
- Risk Assessment
- Severity of Illness Index
- Siblings
- Stem Cell Transplantation -- mortality
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.